CROI 2014: Microbicides
Two prominent members from AVAC’s Global Advocacy for HIV Prevention team expound on the paradigm shift that is occurring around the nomenclature for ‘long lasting’ treatments. New options for HIV prevention exist and are in development, remaining challenges include how to leverage these technologies for achieving transmission reduction. Presentations at CROI are a bridge between basic science and clinical science, and CROI is recognizing that in order to apply new prevention technologies there needs to be a consumer forum for the behavioral component necessary that will be necessary for success. The new Federal budget and the impact of financial investment is discussed, the role of patient responsibility in clinical trial participation, and the importance of community representation in the trial planning process to plan the future.